MOMA Therapeutics

Targeting the molecular machines of human disease

Cambridge, United States · Founded 2020 · $236.0M raised

Employees
51–200
Founded
2020
Business Model
B2B
Website
momatx.com
Total Funding
$236.0M
Last Round
$150.0M Series BMay 2022
Rounds
2

About

MOMA Therapeutics is a clinical-stage precision medicine company dedicated to discovering the next generation of therapies by targeting highly dynamic molecular machines — a class of enzymes that underlie human disease. The company's platform focuses on small molecule drug discovery across oncology and other areas of significant unmet need, leveraging advances in genetics and functional genomics.

Summary

MOMA Therapeutics is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $236.0M in total across 2 rounds, most recently a $150.0M Series B round in May 2022. Investors include Third Rock Ventures, Goldman Sachs and Rock Springs Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BMay 2022
$150.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MOMA Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/moma-therapeutics"><img src="https://indexed.vc/api/badge/company/moma-therapeutics" alt="MOMA Therapeutics on Indexed.vc" width="260" height="76" /></a>